Abstract:Porcine reproductive and respiratory syndrome virus (PRRSV) has been mainly responsible for the heavy economic losses in many swine-producing regions. Current vaccination strategies and antiviral drugs provide only limited protection. Consequently, there is a need to develop a new antiviral strategy. In this study, two recombinant adenoviruses expressing short-hairpin RNAs (shRNAs) directed against ORF1b of PRRSV S1 strain were constructed and the inhibition of PRRSV replication was determined. The results showed that pretreatment with these shRNAs delivered by recombinant adenovirus could induce a significant inhibition of viral RNA and protein level in Marc-145 cells infected with PRRSV S1 strains. One recombinant adenovirus (rAd-P2) was found to be also effective in inhibiting the replication of highly virulent PRRSV SY0608 strain in Marc-145 cells and porcine alveolar macrophages at both the protein and ORF1b mRNA level. The antiviral effect was dose-dependent and sustained for at least 96h. Twenty 6-week old piglets were assigned to four groups each with five piglets. Groups 1 and 2 were inoculated intramuscularly with rAd-P2 and mock construct rAd-mP2 individually. After 24h, groups 1, 2 and 3 were challenged intramuscularly with the SY0608 strain. Group 4 remained unchallenged but with PBS as mock. The results showed that the viral load of PRRSV in serum and lung tissue of swine was suppressed effectively by rAd-P2. The clinical signs and pathological lesions in the pigs inoculated with rAd-P2 were milder than those in rAd-mP2 negative and PRRSV control. These results indicated that shRNAs mediated by the adenovirus could inhibit PRRSV infection sufficiently in vitro as well as in vivo. RNAi mediated by recombinant adenovirus might be a potential new tool for controlling PRRSV infection. Of course, the protective efficiency of rAd-P2 should be made by using a large number of pigs in future.

Protective Efficacy of Adenovirus-Mediated Small Interfering RNAs Against Encephalomyocarditis Virus Challenge in Mice.

Inhibition of Encephalomyocarditis Virus Replication by Shrna Targeting 1C and 2A Genes in Vitro and in Vivo

Inhibition of encephalomyocarditis virus replication by shRNA targeting 1D and 3AB genes in vitro and in vivo

Protective Immune Response in Mice Vaccinated with a Recombinant Adenovirus Containing Capsid Precursor Polypeptide P1, Nonstructural Protein 2A and 3C Protease Genes (P12A3C) of Encephalomyocarditis Virus.

Specific small interfering RNAs-mediated inhibition of replication of porcine encephalomyocarditis virus in BHK-21 cells.

Enhancement of Mouse Immune Response by Recombinant Adenovirus Co-Expressing VP1-2A of Foot-and-mouth Disease Virus and Porcine IFN-α

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Adenovirus-Mediated RNA Interference Both in Porcine Alveolar Macrophages and Swine.

Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies Against PRRSV and CSFV in Mice.

The Influence of Recombinant Adenovirus Expression Multiple Epitopes Genes of Foot and Mouth Disease Virus on Specific Immune Responses in Mice

Protection of Guinea Pigs and Swine by a Recombinant Adenovirus Expressing O Serotype of Foot-and-mouth Disease Virus Whole Capsid and 3C Protease.

Adenovirus-mediated Shrna Interference Against Porcine Circovirus Type 2 Replication Both in Vitro and in Vivo

Inhibition Of Sars-Cov Gene Expression By Adenovirus-Delivered Small Hairpin Rna

Construction of Recombinant Adenovirus Co-expressing VP1-2A of Foot and Mouth Disease Virus and Porcine IL-2 and Its Immune Effects

Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.

The Enhance of Mice Immune Response by Porcine IFN- α on Foot and Mouth Disease Recombinant Vaccine

Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection

Pathogenicity and molecular analysis of an encephalomyocarditis virus isolate from mideastern China.

Enhanced Immune Responses Against Japanese Encephalitis Virus Using Recombinant Adenoviruses Coexpressing Japanese Encephalitis Virus Envelope and Porcine Interleukin-6 Proteins in Mice.

Construction and Immunogenicity of Recombinant Adenovirus Expressing the Capsid Precursor Polypeptide P1 and P12A Plus 3C Proteinase of Encephalomyocarditis Virus

Effective Suppression of Replication of Porcine Reproductive and Respiratory Syndrome Virus by Adenovirus-Mediated Small Interfering RNAs Targeting ORF1b, 5 and 7 Genes

Encephalomyocarditis virus 2C protein antagonizes interferon-β signaling pathway through interaction with MDA5.